FASN and ovarian cancer: Further, ubiquitination assays showed that USP43 reduced FASN ubiquitination in ovarian cancer cell lines (Fig. 6A) and The C110S mutant attenuated the ability of USP43 to hydrolyze ubiquitin chains on FASN (Fig. 6B).